Literature DB >> 3939136

Doxorubicin-dependent lipid peroxidation at low partial pressures of O2.

C C Winterbourn, J M Gutteridge, B Halliwell.   

Abstract

Doxorubicin semiquinone, produced by reduction of doxorubicin with xanthine oxidase or ferredoxin reductase, reacted with H2O2 to cause deoxyribose oxidation that was catalysed by sub-micromolar concentrations of complexed iron. Both the mechanism of deoxyribose oxidation and the yield of oxidation products depended on the chelator. With EDTA or diethylenetriamine penta-acetic acid (DTPA), the reactive species behaved like free . OH. However, when ADP or no chelator was present, oxidation of deoxyribose was inhibited by mannitol but not benzoate or formate and was apparently not due to free . OH. Doxorubicin semiquinone and H2O2 caused peroxidation of phospholipid liposomes when ADP or no chelator was present, but not in the presence of EDTA or DTPA. Lipid peroxidation was iron dependent over a 0.1 to 1 microM range and was maximal with a pO2 of approximately 1.5 mm Hg, when the inhibitory effect of O2 on initiation is balanced by its stimulatory effects on propagation. The results imply that H2O2 and the doxorubicin semiquinone at low iron and O2 concentrations are very effective at initiating lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3939136     DOI: 10.1016/0748-5514(85)90028-5

Source DB:  PubMed          Journal:  J Free Radic Biol Med        ISSN: 0748-5514


  29 in total

1.  Aerobic exercise affects C57BL/6 murine intestinal contractile function.

Authors:  Claudio Andre Barbosa de Lira; Rodrigo Luiz Vancini; Silvia Saiuli Miki Ihara; Antonio Carlos da Silva; Jeannine Aboulafia; Viviane Louise Andree Nouailhetas
Journal:  Eur J Appl Physiol       Date:  2008-02-14       Impact factor: 3.078

2.  Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.

Authors:  Mandeep Atwal; Rebecca L Swan; Chloe Rowe; Ka C Lee; David C Lee; Lyle Armstrong; Ian G Cowell; Caroline A Austin
Journal:  Mol Pharmacol       Date:  2019-08-09       Impact factor: 4.436

3.  Short-term creatine supplementation decreases reactive oxygen species content with no changes in expression and activity of antioxidant enzymes in skeletal muscle.

Authors:  Lucas Guimarães-Ferreira; Carlos Hermano J Pinheiro; Frederico Gerlinger-Romero; Kaio F Vitzel; Renato T Nachbar; Rui Curi; Maria Tereza Nunes
Journal:  Eur J Appl Physiol       Date:  2012-03-14       Impact factor: 3.078

4.  One- and two-electron reduction of 2-methyl-1,4-naphthoquinone bioreductive alkylating agents: kinetic studies, free-radical production, thiol oxidation and DNA-strand-break formation.

Authors:  C Giulivi; E Cadenas
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

5.  Toxicity of t-butylhydroperoxide in hepatocyte monolayers exposed to hypoxia and reoxygenation.

Authors:  A K Costa; D F Heffel; T M Schieble; J R Trudell
Journal:  In Vitro Cell Dev Biol       Date:  1987-07

6.  Effects of indole-3-acetic acid on croton oil- and arachidonic acid-induced mouse ear edema.

Authors:  L H Jones; D S Abdalla; J C Freitas
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

Review 7.  Oxidative stress in chemical toxicity.

Authors:  H Kappus
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

8.  Encapsulation of adriamycin in human erythrocytes.

Authors:  A De Flora; U Benatti; L Guida; E Zocchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A.

Authors:  Amy D Hanna; Alex Lam; Steffi Tham; Angela F Dulhunty; Nicole A Beard
Journal:  Mol Pharmacol       Date:  2014-08-08       Impact factor: 4.436

10.  Mitochondrial delivery of doxorubicin by triphenylphosphonium-functionalized hyperbranched nanocarriers results in rapid and severe cytotoxicity.

Authors:  Theodossis A Theodossiou; Zili Sideratou; Maria E Katsarou; Dimitris Tsiourvas
Journal:  Pharm Res       Date:  2013-08-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.